This is a strong conviction buy from a sophisticated healthcare investor with board representation. The $7.5M purchase at 0.58% of market cap is a material signal. However, historical model performance on IMTX has been poor (13% win rate at T+20), suggesting the stock may not respond predictably to insider signals. Watch for upcoming pipeline catalysts or partnership announcements that could validate this insider's thesis.
Price Chart
Executive Summary
Director Perceptive Advisors LLC purchased 863,060 shares of Immatics N.V. for $7.5M at $8.69/share in a single open-market transaction. This is a large, conviction buy by a healthcare-focused investment firm that is also a director, representing approximately 0.58% of the company's $1.3B market cap. The purchase signals strong insider confidence in the company's pipeline prospects, though historical model performance on IMTX has been poor with a 13% win rate at T+20.
Key Financial Metrics
Key Facts
- Director Perceptive Advisors LLC purchased 863,060 shares at $8.69/share for a total of $7.5M
- The purchase represents ~0.58% of IMTX's $1.3B market cap
- This is the only insider trade in the last 30 days, and the only trade in the last 7-day cluster window
- The buyer is a healthcare-focused investment firm with a board seat, making this a high-conviction signal
- IMTX has 94% analyst bullishness (15 Buy, 1 Hold, 0 Sell)
Financial Impact
Director purchased $7.5M of stock at $8.69/share, representing 0.58% of market cap
Risk Factors
- Historical model performance on IMTX is poor with 13% win rate at T+20
- Single insider trade, even by a director, may not be as predictive as a C-suite cluster
- Biotech stock volatility could overwhelm the signal from this purchase
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001193125-26-371237 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | Insider Buy | $9.45 $8.50 | ▼ −10.05% | ▼ −10.31% | $7.59 (−19.68%) |
Aug 26, 2026 5w ago | 6-K | $9.36 $8.33 | ▲ +11.00% | ▲ +10.50% | $7.59 (+18.91%) |
Aug 18, 2026 6w ago | 6-K | $9.09 $8.82 | ▼ −2.97% | ▼ −1.98% | $7.59 (−16.50%) |
Aug 18, 2026 6w ago | Press Release | $9.09 $8.82 | ▼ −2.97% | ▼ −1.98% | $7.59 (−16.50%) |
Jun 2, 2026 17w ago | 6-K | $10.04 $9.85 | ▼ −1.89% | ▼ −0.33% | $7.59 (−24.40%) |
Jun 1, 2026 17w ago | 6-K | $11.14 $10.13 | ▼ −9.07% | ▼ −7.77% | $7.59 (−31.87%) |
Jun 1, 2026 17w ago | Press Release | $11.14 $10.13 | ▼ −9.07% | ▼ −7.77% | $7.59 (−31.87%) |
May 31, 2026 17w ago | Press Release | $11.14 $10.13 | ▼ −9.07% | ▼ −7.77% | $7.59 (−31.87%) |
May 30, 2026 17w ago | Press Release | $11.14 $10.13 | ▼ −9.07% | ▼ −7.77% | $7.59 (−31.87%) |
May 12, 2026 20w ago | 6-K | $11.39 $8.87 | ▲ +22.12% | ▲ +20.40% | $7.59 (+33.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access